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Abstract 
Antimicrobial resistance (AMR) is a serious and growing threat to human health. The development 
of new antibiotics is limited and slow.  The tradition of synergy in herbal medicine is being used 
as a source of research ideas.  A literature review of antimicrobial research and plant synergy 
published in a five year period was carried out using online databases. The in vitro findings were 
that most of the research reported synergy both within plants and between plants and antibiotics. 
Whole plant extracts and combinations of compounds were shown to be more effective 
antimicrobials than isolated constituents.  The discussion highlights that the in vitro herbal 
research findings are difficult to apply to practice and aren’t progressing to clinical trials.  
Collaborative, innovative, inter-disciplinary clinical research is recommended. 
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 Abbreviations 
 
AMR   Antimicrobial Resistance 
DOH   Department of Health 
DEFRA Department for Environment, Food and Rural Affairs 
EBM  Evidence Based Medicine 
ECDC  European Centre for Disease Prevention and Control 
EHTPA European Herbal and Traditional Practitioners Association 
EPI  Efflux Pump Inhibitors 
FIC   Fractional Inhibitory Concentration 
MIC   Minimum Inhibitory Concentration 
MDR             Multiple Drug Resistance 
MRSA           Methicillin resistant Staphylococcus aureus 
WHO  World Health Organisation 
 1. Introduction 
 
Health professionals, governments and international organisations are increasingly reporting the 
risks of antimicrobial resistance (AMR) to global health security.  At a low estimate antibiotic 
resistance is currently causing 700,000 deaths worldwide annually, with this figure projected to 
reach 10 million by 2050 (O’Neil, 2014).  The European Centre for Disease Prevention and Control 
(ECDPC) recently reported significant and increasing Multiple Drug Resistance (MDR) in 
Escherichia coli and Klebsiella pneumonia in more than a third of the countries that they report 
on (ECDPC, 2015).  AMR increases the duration of illness and risk of death and has been 
predicted to make modern medical care impossible (Davies, 2013) with surgery and 
chemotherapy potentially becoming high risk interventions. 
   
The World Health Organisation (WHO) reports that there are internationally high levels of AMR in 
common bacteria alongside limited understanding and uncoordinated surveillance of AMR (WHO, 
2014).  There have been just two new classes of antibiotics developed in the last 40 years. The 
development pipeline is slow and although two new Cephalosporin combinations are expected to 
be licensed in Europe soon for use in humans, AMR will also emerge for these (O’Neil, 2015).  
Bacterial mechanisms for resistance are innate but the high correlation between antibiotic use 
and AMR is clear (ECDPC, 2015).  Further research, development of collaborative working, novel 
approaches to prevent and treat infections and the exploration of possibilities for enhancing 
immunity (in relation to infection by bacteria) including using prebiotics and probiotics have been 
recommended (DOH and DEFRA, 2013).  Research and approaches for improving human 
immunity and resilience have been lacking (EUROCAM, 2014). WHO (2012) advises innovation 
and testing natural products to address AMR.   
 
1.1. Antimicrobial resistance   
Bacteria are prokaryotic micro-organisms, some of the earliest life forms, which created planetary 
conditions hospitable to animal life.  There have been debates since the nineteenth century about 
whether diseases are caused by bacteria or the environment of a vulnerable, internally 
imbalanced body (EUROCAM, 2014).  The dominant narrative of human relationship with bacteria 
has been the germ theory of disease which posited bacteria as enemies and motivated a war on 
them (Amyes, 2001).  Kourtesi, et al. (2013) wrote of a subsequent mind-set that this war had 
later been won with the discovery of antibiotics.  Antimicrobial refers to a substance with inhibitory 
action on either the growth or survival of micro-organisms (Davies, 2013).  More specifically, 
antibiotics are naturally derived, largely antibacterial agents (Markovitch, 2010).  A bacterium has 
 intrinsic mechanisms for protection.  The thick hydrophobic outer membrane of Gram negative 
bacteria and mycobacteria contributes to a greater resistance than Gram positive bacteria (Stavri 
et al., 2007).  Efflux pumps remove toxins including clinical antibiotics out of the bacterium’s cells.  
Increased production of efflux pumps is considered a main mechanism of bacterial resistance 
(Junio et al., 2011) particularly for multi-resistant Gram negative bacteria (Levy, 2002, Garvey et 
al., 2011and Betts et al., 2012.)  Efflux pump inhibitors (EPI) are being researched to enable future 
efficacy of antibiotics but Buhner (2002) and Levy (2002) caution of the danger of this approach 
due to the ability of bacteria to quickly evolve into more harmful forms.  
 
A variety of factors, including over reliance on antibiotics in healthcare and farming have caused 
bacteria to evolve and develop additional mechanisms of bacterial resistance in order to survive 
(Levy, 2002).  It is well recorded but not fully understood how multiple drug resistance (MDR) can 
be developed in bacteria in a human or animal body through two weeks use of just a single 
antibiotic. 'It is almost as if bacteria strategically anticipate the confrontation of other drugs when 
they resist one' (Levy, 2002).  The surprising extent of transferable drug resistance between 
different species of bacteria is understood to occur through horizontal genetic transfer of mobile 
traits (Smillie et al., 2011).   
 
Blaser (2014), director of the Human Microbiome Project at New York University, describes how 
the trillions of microbes which have co-evolved to live with a species make up its microbiome.  
Blaser (2014) reports that 70-90% of cells in a human body are microbial symbionts, carrying out 
a range of important metabolic and protective functions.  Gilbert et al. (2012) reported that in 
contemporary biology symbiosis is a core principle.  They state that the old views of the immune 
system as 'defence,' 'weaponry' and 'self/non-self discrimination' are being inverted as it is 
increasingly understood that the microbiome co-creates the immune system (Gilbert, et al., 2012).  
In symbiotic biology, dynamic co-evolution with microbial symbionts is important to all mammals 
and research is finding ever greater microbial diversity and increasingly complex interrelating 
(Gilbert, et al., 2012).  In all ecosystems diversity is crucial.  After 30 years researching bacteria 
and human disease, Blaser (2014) argues that overused medical interventions (particularly 
antibiotics) have reduced the diversity of the human microbiome with damaging consequences to 
human health.  In contrast to the understandings which led to the so called war on bacteria, 
contemporary research appears to be in the early stages of facilitating a paradigm shift in 
understandings of the human microbiome.   
 
 
 1.2 Plants and bacteria 
Plants can be described as complex, adaptive, synergistic systems (Niemeyer, et al., 2013).  The 
low levels of infectious diseases found in wild plants, in contrast to crop plants  (Hemaiswaya, et 
al., 2008) have been attributed in part to synergistic effects of multiple mildly antibacterial 
constituents and other hypothesised actions such as EPI (Buhner, 2012 & Brown, 2015).  Plants 
are understood to have co-evolved with pathogens and therefore developed effective chemical 
responses (Datta, et al., 2011).  Plants in the wild are found to exhibit moderate antibacterial 
activity rather than entirely destroy the infectious species (Buhner, 2002). Plants and bacteria 
share a 'genetic fluidity' whereby they can respond to environmental stressors by rearranging their 
genotype (Buhner, 2002).  Kourtesi, et al. (2013) state that plants respond to microbial threat 
significantly differently to the microbes which produce antibiotics, with plants instead evolving a 
complexity of synergists and toxins.  Buhner (2012) observes the developing resistance of malaria 
parasites to artemisinin, a constituent of Artemisia spp. and argues that this will always happen 
with single constituent drugs whatever their origin.   
 
1.3 Synergy 
From a scientific perspective the challenge of synergy is that the concept, by its definition, lies 
outside the current belief that wholes, in this context a whole plant extract, can be understood by 
the isolation and analysis of its parts.  Plant synergy is not considered a rational approach to the 
combination of molecules.  Numerous mathematical models have been proposed in the quest for 
a quantitative measurement of synergy, the definition of which tends to be defined by the precise 
mathematical method used to demonstrate it.  Berenbaum (1989) and Greco et al. (1995) review 
these methods which, because they were mainly designed to assess the interaction of 
pharmaceutical drug combinations, do not take into account the multiple compounds, actions, 
interactions and effects of whole herb preparations and formulae.  Williamson (2001) in a review 
on plant synergy cited the isobole method as proposed by Berenbaum (1989) as the current 
method of choice. 
 
Combination antimicrobial therapy, with some synergistic effects, is used successfully in 
chemotherapy, malaria and TB treatment and other specific scenarios but is not supported by the 
evidence for Gram negative bacterial infections (Tamma et al., 2015). It is recommended for Gram 
negative bacterial infections that the bacteria are rapidly identified and targeted in order to save 
future use of antibiotics (Tamma et al., 2015). 
 
 
 1.4 The synergistic approach 
 
Herbal medicine’s uniqueness is due to its use of combinations of herbs and to the interactions 
(synergistic, additive or antagonistic) between constituents (Heinrich et al., 2012).  Synergy is an 
effect of a combination of substances which is greater than would be expected by adding together 
their separate contributions (Williamson, 2001).  There is currently much research aimed at 
identifying and isolating secondary metabolites of plants with antimicrobial activity (Rahman, 
2014).  Williamson (2001) discusses the limitations of isolated constituent research and advocates 
for more synergy research.  The European Herbal and Traditional Practitioners Association 
(EHTPA) state that the synergism of phytoconstituents is significant in herbal pharmacokinetics 
and pharmacodynamics and may be a resource for responding to AMR (EHTPA, 2013).  Heinrich, 
et al. (2012) state that although there is much interest in synergy and although it is held as a key 
factor in herbal medicine, it is not well written about or recorded. This paper aimed to review 
recent synergy research, in relation to AMR, both within herbal medicines and between plants 
and antibiotics.   
 
2. Methodology 
A literature search was conducted in May 2014 using keywords: antimicrobial OR antibiotic OR 
antibacterial AND synergy* AND plant OR herb* OR natural. Electronic databases were searched: 
Ebsco HOST, Pub Med, Science Direct and the following journals: Planta Medica and 
Phytotherapy Research.  Inclusion criteria were synergy research involving plants with 
antibacterial activity with or without antibiotics, published in peer reviewed journals in English 
between January 2010 and May 2014.  It was outside the scope of this paper to cover the 
significant body of synergy research from Traditional Chinese Medicine or the research into the 
antimicrobial properties of essential oils.  Reference lists of the identified research were hand 
searched and additional research traced online.   
 
3. Results 
 3.1 Literature review: antimicrobial research and plant synergy  
 
The following summary represents an overview of the literature that met the inclusion criteria for 
synergy research involving plants with antibacterial activity.  Table 1 outlines methods for 
antimicrobial synergy research used or discussed in the research or literature.  The studies which 
met the inclusion criteria are all in vitro.  The disc diffusion assay and MIC measurement methods 
(Table 1) are used to explore in vitro assessments of antimicrobial activity of plant extract(s), 
 fractions and pure compounds isolated from extracts or fractions in comparison with antibiotics.  
Synergy is tested using similar methods by applying a combination of antibiotic and plant extract 
or combination of compounds.  Unlike pharmaceutical drugs where an exact dose of the active 
principle can be measured, the active principle in a whole plant extract is notoriously variable. To 
try and eliminate as many variables as possible, the use of plant extracts standardised to known 
active constituents is generally preferred for scientific validity (Williamson 2001). 
 
 
Table 1. Methods for researching antimicrobial synergy 
 
Method 
 
Process 
Disc diffusion  
 
 
Antibiotic and other solutions are tested on agar plates which have bacteria 
evenly spread over them.  Individual and combinations of constituents at 
varying dilutions are applied to the agar on paper discs or in wells cut out of the 
agar before incubation of plates.  Zones of inhibition are measured (diameter in 
mm) to show antimicrobial activity (Rahman, 2014).  The size of the zones of 
inhibition depends upon the diffusion of the active compounds into the agar. An 
active non-polar compound may give only a small zone of inhibition because it 
will not diffuse through the polar agar very well.  Therefore the data is of limited 
value for researching synergy as it cannot be used to compare the activities of 
different compounds/extracts.  Disc diffusion assay is comparatively straight 
forward, time efficient, affordable and appropriate for researching plant 
materials (Rahman, 2014). 
 
Minimum inhibitory 
concentration (MIC) 
assay 
The minimum inhibitory concentration (MIC) is the lowest concentration of a 
tested substance at which no bacterial growth can be seen (Bone and Mills, 
2013).  For this purpose a method such as the disc diffusion assay should be 
used, but even with this method, test substances need to be soluble in the 
culture medium to display activity. 
 
Fractional inhibitory 
concentration (FIC) in 
Checkerboards assay 
In the checker board assay (Orhan et al., 2005), an amount (e.g. 50-100 μl) of 
Mueller-Hinton broth is dispensed into all wells of the microdilution plates 
followed by the addition of an antibiotic or first compound/ extract of the 
combination which are serially diluted along the ordinate, whilst the compound/ 
extract or the second sample serially diluted along the abscissa. Each well is 
inoculated with a volume (e.g.100 μl) of a bacteria followed by incubation under 
standard conditions. The resulting checkerboard contains each combination 
with wells containing the highest concentration of each sample at opposite 
corners. Synergy is expressed as ΣFICs which is calculated as  
ΣFIC = FIC 1 + FIC 2, where FIC 1 is the MIC of sample 1 in the combination/ 
MIC of sample 1 alone, and FIC 2 is the MIC of sample 2 in the combination/ 
MIC of sample 2 alone. The combination is synergistic if the ΣFIC is ≤0.5, 
indifferent if the ΣFIC is >0.5 to <2, and antagonistic if the ΣFIC is ≥2. 
 
The isobole method Both in vitro and in vivo bioassays can be used to demonstrate the isobole of a 
mixture of two materials (two extracts, one extract plus a compound or two 
compounds). This method provides a graph of x and y axis representing the dose 
of the single individual components. (Fig. 1). The combined doses are expressed 
by geometric points with coordinates which correspond to the individual doses 
of each components in the mixture. An isobole is considered to be a line or curve 
between points of the same activity. If the point representing a combination of 
 two substances forms a straight line with single points on the x-y axis, there is 
no interaction.  If the point representing the effect of the combination lies below 
this line, the curve will be concave-up indicating that synergy is present.  A point 
above this line produces a concave-down isobole indicating antagonism (Fig. 1). 
Wagner and Steinke (2004) have successfully employed this method to assess 
synergy between various mixtures of ginkgolide A and B (constituents of Ginkgo 
biloba) measured using the thrombocyte aggregation assay.  Wagner (2004) 
comments however, that although this method may be suitable for dose-
response investigations with two-component containing mixtures, it is not a 
plausible method to be applied to herbal extract mixtures which would require 
detailed in vitro or in vivo comparative investigations with single constituents or 
mixtures and extract fractions or whole extracts to be performed. 
 
Death kinetic (time-kill) 
assays 
This method records antimicrobial activity over time and is clinically 
commended but not much used in research with plants.  It is argued to be 
advantageous over MIC assays as it can show effects over time (van Vuuren 
and Viljoen, 2011). These assays would be used if a promising 
compound/extract is identified following MIC assays. 
 
Synergy directed 
fractionation 
Comprehensive mass spectrometry profiling combined with synergy assays 
and isolation of constituents (Junio, et al., 2011); see section 3.4. 
 
 
 
 
Figure 1.   Isobologram illustrating additivity, synergy, and antagonism (Topps and Busia, 2005).  
A1 and B1 are the doses of the constituents A and B respectively, which produce an equal effect.  
The concave up isobole represents synergy.  The concave down isobole represents antagonism. 
 
 
 
 
 
 
 
 
 3.2 Minimum inhibitory concentration (MIC) 
 
Lee and Lee (2010) used the disc diffusion assay to research individual antimicrobial effects and 
combined actions of Olea europea phenolics.  No positive control antibiotics were included in the 
research methodology and the methodology was limited to disc diffusion studies so that the data 
are of limited value.  The phenolics were tested individually and in combination in the ratios 
present in olive leaf extract.  Zones of inhibition were measured against both Gram-negative 
bacteria such as Escherichia coli and Salmonella enteritidis and Gram-positive bacteria such as 
Bacillus cereus and Staphylococus aureus (Lee and Lee, 2010).  A significant difference was 
detected in the antimicrobial activity whereby the phenolics mixture presented higher inhibition 
effects than the individual phenolics against Bacillus cereus and Salmonella enteritidis (p < 0.05).  
Further studies would need to be carried out to determine the potency of the compounds 
compared to known antimicrobials using a suitable quantitative assay and also to determine the 
degree of synergy between compounds.  Ncube et al. (2012) researched three South African 
medicinal bulbs with both Gram-negative and Gram-positive bacteria. The antimicrobial 
interactions of extract combinations were assessed with microdilution assays and MIC 
measurements and then checkerboard method and FIC calculations (Ncube et al., 2012).  The 
researchers found synergistic interactions indicated by the FIC indices for at least one of the 
extract combinations for each plant, including where one of the combinations had an FIC of 0.1 
against Staphylococcus aureus although the individual MIC of each extract component against 
the same bacteria was 12.5mg/ml (Ncube et al., 2012).  The researchers reported more 
synergistic interactions with non-polar compounds than polar (Ncube et al., 2012) and linked this 
with previous findings of higher antimicrobial activity in non-polar extracts. 
 
Adwan et al. (2010) used broth microdilution and synergy assay to find in vitro interactions 
between three Palestinian plant materials, five antibiotics and three strains of multi-drug resistant 
Gram negative bacteria Pseudomonas aeruginosa. The choice of bacteria was explained but not 
of plant species or plant parts.  The growing conditions, harvesting and identification of plant 
materials were not transparent but the preparation of plant materials was explained.  The authors 
used controls and measured the MIC of the antibiotics and plant extracts separately and in 
combination in duplicates.  Adwan et al. (2010) found that the MIC decreased in the combinations 
particularly with Rhus coriara (seed) and attributed this to synergistic effects although the authors 
did not utilise the FIC index or the isobole method.  For example Penicillin MIC >100, Rhus coriara 
MIC (3.125-1.563) x 10³, Rhus coriara + Penicillin <0.012.2. The researchers went on to work on 
 the identification of active constituents and highlighted the need for further work on the most 
effective plant-drug ratios, in vivo experiments and controlled clinical trials (Adwan et al., 2010).   
 
 
Wang et al. (2013) conducted research with MRSA strains of Staphylococcus aureus and an 
ethanol extraction of a Tibetan medicinal plant Sophora moorcroftiana and found that constituents 
without antibacterial activity were significant synergists.  Isolated compounds displayed less 
antibacterial activity than the extract (Wang et al., 2013), which could be attributed either to 
changes occurring during isolation procedures or synergy.  By measuring the MIC values, 
calculating fractional inhibitory concentration (FIC) indices and conducting efflux assay tests it 
was concluded that the synergist compounds were genistein which had a moderate EPI action 
and diosmetin which had no EPI action with these bacteria but had a strong synergistic effect by 
a different mechanism (Wang et al., 2013). 
 
3.3. Fractional inhibitory concentration (FIC) 
 
Betts et al. (2012) tested tea polyphenols (theaflavin) with an antibiotic (Ampicillin) against clinical 
isolates of Gram negative multi drug resistant Stenotrophomonas maltophilia from hospital 
patients.  Betts et al. (2012) found that when the antibiotic was used with theaflavin the MIC 
decreased from 12.5-22.9 μg/mL to 3.125-6.25 μg/mL to give a significant synergy FIC index of 
0.22-0.35 (Table 1).  The isobole method has been argued to be more accurate than the FIC index 
as it is more responsive to dose differentials (van Vuuren and Viljoen, 2011) but the research by 
Betts et al. (2012) did not use or mention this method. The authors did however highlight 
differences between the disc diffusion and microtitre assay, the former involving agar and 
therefore temperature and pH related variations in diffusion (Betts et al., 2012).  In contrast, the 
microtitre assay (using a plate manufactured with wells) was preferred by the authors as it was 
not dependent on those variations and was rather more readily standardised and more accurate 
(Betts et al., 2012).  Betts et al. (2012) concluded that further research is needed into mechanisms 
of action and emphasise the possibility for future effective clinical use of polyphenols with 
antibiotics in the context of antibiotic resistance. 
 
Garvey et al. (2011) screened eighty four extracts of twenty one plants, 12 fractions thereof and 
2 purified molecules for synergy with the antibiotic Ciprofloxacin against Salmonella enterica 
(Gram-negative bacteria). They used the microtitre method and presented FIC index values 
agreed to be indicative of synergy.  Extracts of Melissa officinalis and Levisticum officinale were 
 found to have independent antimicrobial activity against the Gram-negative bacteria and to have 
the greatest antibiotic potentiation effect (Garvey et al., 2011). They also investigated efflux pump 
inhibition capability of plant extracts. The highest efflux pump inhibition activity was revealed by 
the extracts of L. officinale. However, the synergistic activity of the plant extract was lost which 
might be either through alteration, inactivation or the separation of synergistic compounds as 
suggested by the authors. 
 
 3.4. Synergy directed fractionation 
Bioassay guided fractionation is commonly carried out to find out the compound(s) responsible in 
the complex plant preparations. In this case, the active extracts are subjected to chromatographic 
techniques for the purification of compounds followed by their identification by spectroscopic 
methods. One drawback of this fractionation for studying botanical medicines is that it may not 
facilitate the identification of synergists which normally do not have the activity on their own but 
potentiate the activity of others. So during bioassay guided fractionation the potentiators may be 
overlooked. In order to address such challenges, Junio et al (2011) demonstrated synergy di-
rected fractionation which involved the addition of an active compound at a fixed concentration to 
the extracts/ fractions which were subjected to synergy assays followed by the isolation of com-
pounds from the extracts/ fractions of natural products. Junio et al (2011) used broth microdilula-
tion antimicrobial checkerboard assays (Table 1) to evaluate the synergy of crude extracts in 
presence of berberine at a concentration of 5-300 µg/ml. The crude extracts were fractionated 
and subjected to synergy testing in the presence of berberine using the same checkerboard assay. 
Among the fractions, a 16-fold decrease of the MICs (from 75 to 4.7) of berberine was observed 
in fraction 4 which was then further subjected to flash chromatography and HPLC whereby three 
flavonoids were isolated- sideroxylin, 8-desmethyl-sideroxylin and 6-desmethyl-sideroxylin.  Junio, 
et al. (2011) reported that these three flavonoids were synergistic in the antimicrobial activity of 
berberine against Staphylococcus aureus by inhibiting the Nor multidrug resistance pump.  As 
Hydrastis canadensis roots are higher in alkaloids and the leaves higher in flavonoid synergists, 
the authors concluded that an extract against Staphylococcus aureus might be produced by mix-
ing both roots and leaves and that the effectiveness of botanical medicine is the result of diverse 
constituents acting together Junio, et al. (2011).  Although other authors considered possible and 
likely mechanisms of action Junio, et al. (2011) were the only ones to establish this through their 
methodology.     
 
In this review, antibacterial synergy was reported for Olea europea (Lee and Lee, 2010), Hydrastis 
canadensis (Junio et al., 2012), Tulbaghia violacea, Hypoxis hemerocallidea and Merwilla 
 plumbea (Ncube et al., 2012) and Sophora moorcroftiana (Wang et al., 2013).  Antibacterial 
synergy between plants and antibiotics was reported for: Rhus coriara (Adwan, et al., 2010), the 
polyphenol theaflavin (Betts, et al., 2012), Melissa officinalis and Levisticum officinale (Garvey et 
al., 2011).   
 
 
 4. Discussion    
Stavri et al. (2007) reported that most synergy research involving plants was on Gram-positive 
bacteria.  Three of the studies in this review involved the clinically difficult to treat Gram-negative 
bacteria, two researched with Gram positive Staphylococcus aureus and two involved both Gram-
negative and Gram-positive strains.  Diffusion assay and measurement of zones of inhibition offer 
an indication of interactions but require cautious evaluation due to a multitude of influencing 
factors (van Vuuren and Viljoen, 2011), for example issues with solubility of compounds.  As 
synergistic effects may occur at different concentration ratios, Heinrich et al. (2012) report that 
the isobole method is the agreed method of choice.  Bone and Mills (2013) state that it is the only 
'truly rigorous' evidence of synergy but that its complexity deters researchers.  Junio et al. (2011) 
were the only researchers to plot an isobologram and their integration of several methodologies, 
(synergy directed fractionation), enabled the identification of active constituents whose synergistic 
activity might be missed by other methods (as they were not directly antimicrobial).   
 
Bioassay guided isolation and fractionation (in vitro or in vivo) experiments (Table 1) identify the 
activities of a compound.  However the results may be difficult to interpret due to compounds 
reacting with the extraction solvents though absorption, oxidation, degradation, evaporation 
where heat is used or the separation of unstable components.  The activity of the extract may be 
progressively lost through the process but understanding why is hard to ascertain (Garvey, et al., 
2011).  Heinrich et al. (2012) poses the retention of biological activity following extraction as an 
important question as most extracts are complex and the concentration of active constituents may 
be low.  Almost all the researchers were directly seeking or recommending in conclusions the 
identification of active compounds through bioactivity guided fractionation, however Junio, et al. 
(2011) argued that this approach can miss synergists with indirect actions such as potentiation 
(enhancing another constituent's action) and aim to engage with the complexity of herbal 
medicine through developing a new methodology.   
 
The challenges of relating in vitro findings to in vivo and clinical practice are raised by many 
authors (Adwan, et al., 2010, Gertsch, 2011 and Mills, 2011).  Absorption, metabolism and bioa-
vailability are not predictable from in vitro findings.  Niemeyer, et al. (2013) and others have sug-
gested that the findings of reductionist approaches using processed plant parts and isolated con-
stituents may not be generalisable to herbal medicine practice.  All the research reviewed used 
dried plant extracts although there are researchers (Wright et al., 2010) and herbal medicine 
practitioners finding that traditional, fresh preparations have the best antimicrobial results (Buhner, 
2013).   
  
Chemical complexity and the multi-targeted (polyvalent) nature of herbal medicine are understood 
as therapeutic strengths but make identification of active constituents a difficult goal (Bone and 
Mills, 2013).  Most of the research reviewed here shows that whole plant extracts or combinations 
of compounds are more effective antimicrobials than isolated constituents (Junio et al., 2012), 
(Lee and Lee, 2010), (Ncube et al., 2012), (Wang et al., 2013) and (Garvey et al., 2011).  
Combinations of non-specific mechanisms of action might create a more effective antimicrobial 
than an antibiotic (Kourtesi, et al. 2013).  It has been argued that there is a risk of herbal medicine 
practice being reduced to practitioners prescribing based on the inconclusive findings of 
contemporary reductionist researchers (Niemeyer, et al., 2013).  The presented findings highlight 
the challenges of reductionist methodologies in researching the complexity of plants.  It is yet to 
be understood if plant sourced antimicrobials will be subject to the same AMR as the existing 
antibiotics. This paper agrees that there is a serious risk in attempting to meet AMR with the same 
paradigm of thinking which has created the situation.   
 
5. Conclusion 
This paper reports international findings of antimicrobial synergy within plants and between plants 
and antibiotics.  Laboratory methodologies for plant based antimicrobial synergy research are 
shown to be developing but in vitro herbal research isn't progressing into clinical studies.  The 
discussed methodologies and findings highlight the different paradigms and values in healthcare 
and the political context within which research and healthcare exist.   
 
Contemporary understandings of complex systems science, symbiosis and the microbiome are 
pointing to new ways of seeing and responding to AMR.  It is recommended that these 
perspectives and their developing research methodologies are supported by scientists, policy 
makers and herbal medicine practitioners.  Synergy in herbal medicine can be seen to be 
significant in the context of AMR not just because of antimicrobials and synergists but because it 
adds to these systemic ways of knowing.  From these emerging understandings it is clear that 
both the use and development of antimicrobials need careful consideration for whole systems 
health.  The findings presented in this paper suggest that healthcare could learn much from plants 
and herbal medicine traditions about co-evolving, diversity, adaptability and the complexities of 
synergy.  Collaborative, innovative, inter-disciplinary clinical research is recommended to meet 
the challenge of AMR.  
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